All listings for this product
Best-selling in Textbooks
Save on Textbooks
- AU $27.54Trending at AU $43.90
- AU $80.99Trending at AU $87.85
- AU $72.90Trending at AU $77.47
- AU $71.88Trending at AU $73.18
- AU $82.89Trending at AU $85.35
- AU $72.90Trending at AU $79.34
- AU $34.75Trending at AU $42.60
About this product
- DescriptionGlycoimmulogy, the studyofthe oligosaccharide components ofglycoconjugates as an integral component ofthe immune system, has opened up a rapidly evolving field. It draws from a broad spectrum of techlogies, ranging from classical synthetic organic chemistry, to molecular biology and beyond. The structural microheterogenity ofoligosac- charides found on glycoproteins and glycolipids is immense and reflects the ermous inherent structural diversity of these carbohydrate side chains and their ability to encode information. In this respect glycoimmulogy represents an exciting and significant oppor- tunity for both biotechlogy and pharmaceutical research. This book summarizes the proceedings of the Third Jenner International Glycoim- mulogy meeting, held at IL Ciocco Tuscany in October 1994, which was co-ordinated underthe auspicesofEUROCARB, the EuropeanCommunityConcertedAction forArthritis and Carbohydrate Research. This meeting brought together leading academic and commer- cial researchers at the forefront ofglycosylation and immulogy, with the aimofreviewing and focusing on applied and basic research relating to glycoimmulogy and its clinical implications.
- PublisherSpringer-Verlag New York Inc.
- Date of Publication21/10/2012
- SubjectClinical Medicine: Professional
- Series TitleAdvances in Experimental Medicine and Biology
- Series Part/Volume Number376
- Place of PublicationNew York, NY
- Country of PublicationUnited States
- ImprintSpringer-Verlag New York Inc.
- Content Notebiography
- Weight588 g
- Width178 mm
- Height254 mm
- Spine16 mm
- Edited byAzita Alavi,John S. Axford
- Edition StatementSoftcover reprint of the original 1st ed. 1995
This item doesn't belong on this page.
Thanks, we'll look into this.